Cantor Fitzgerald Cuts Semler Scientific (NASDAQ:SMLR) Price Target to $60.00

Key Points

• Cantor Fitzgerald has lowered their price target for Semler Scientific (NASDAQ:SMLR) from $61.00 to $60.00, while maintaining an "overweight" rating, indicating a potential upside of 73.81% from its current price.
• Other brokerages have varied opinions on SMLR, with one raising its rating to "strong-buy" and a new target price of $95.00, while another downgraded the stock to "sell," showing a lack of consensus among analysts.
• Semler Scientific reported earnings of $5.04 per share for the last quarter, significantly beating the consensus estimate of (\$0.27) per share and generating revenue of $8.22 million.

Semler Scientific (NASDAQ:SMLR - Get Free Report) had its price objective decreased by analysts at Cantor Fitzgerald from $61.00 to $60.00 in a note issued to investors on Wednesday,Benzinga reports. The firm currently has an "overweight" rating on the stock. Cantor Fitzgerald's price objective indicates a potential upside of 66.07% from the stock's previous close.

Several other analysts have also recently commented on the company. Benchmark assumed coverage on Semler Scientific in a report on Tuesday, July 8th. They issued a "buy" rating and a $101.00 target price on the stock. Maxim Group upgraded Semler Scientific to a "strong-buy" rating and set a $95.00 target price on the stock in a report on Wednesday, July 9th. Finally, Wall Street Zen cut Semler Scientific from a "buy" rating to a "sell" rating in a report on Thursday, May 22nd. One investment analyst has rated the stock with a sell rating, three have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, Semler Scientific presently has an average rating of "Moderate Buy" and a consensus target price of $81.75.

Semler Scientific Price Performance

NASDAQ SMLR traded down $1.41 during trading on Wednesday, hitting $36.13. 580,350 shares of the company's stock were exchanged, compared to its average volume of 646,257. The stock's 50 day moving average price is $37.43 and its two-hundred day moving average price is $39.05. Semler Scientific has a fifty-two week low of $21.77 and a fifty-two week high of $81.56. The company has a current ratio of 0.60, a quick ratio of 0.58 and a debt-to-equity ratio of 0.25. The company has a market cap of $535.09 million, a PE ratio of 4.30 and a beta of 1.34.

Semler Scientific (NASDAQ:SMLR - Get Free Report) last released its quarterly earnings data on Monday, August 4th. The company reported $5.04 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.27) by $5.31. Semler Scientific had a return on equity of 43.84% and a net margin of 86.20%. The company had revenue of $8.22 million during the quarter, compared to the consensus estimate of $8.10 million.

Hedge Funds Weigh In On Semler Scientific

A number of large investors have recently modified their holdings of the company. Interchange Capital Partners LLC purchased a new stake in shares of Semler Scientific during the 1st quarter valued at $46,502,000. Capital International Investors purchased a new stake in shares of Semler Scientific during the 4th quarter valued at $30,813,000. Susquehanna Advisors Group Inc. purchased a new stake in Semler Scientific in the 4th quarter worth about $26,928,000. Driehaus Capital Management LLC purchased a new stake in Semler Scientific in the 4th quarter worth about $10,122,000. Finally, Invesco Ltd. purchased a new stake in Semler Scientific in the 4th quarter worth about $5,964,000. 49.37% of the stock is currently owned by institutional investors.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.